Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,981 | 446 | 99.9% |
| Education | $6.02 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $718.04 | 70 | $0 (2024) |
| GlaxoSmithKline, LLC. | $674.84 | 46 | $0 (2024) |
| Amgen Inc. | $634.16 | 46 | $0 (2024) |
| PFIZER INC. | $622.40 | 48 | $0 (2024) |
| ABBVIE INC. | $428.72 | 32 | $0 (2024) |
| Novo Nordisk Inc | $337.68 | 29 | $0 (2024) |
| Astellas Pharma US Inc | $293.77 | 20 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $223.57 | 18 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $223.21 | 18 | $0 (2024) |
| Merck Sharp & Dohme LLC | $193.59 | 18 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,029 | 63 | Lilly USA, LLC ($187.71) |
| 2023 | $1,200 | 74 | GlaxoSmithKline, LLC. ($174.66) |
| 2022 | $996.67 | 76 | ABBVIE INC. ($139.33) |
| 2021 | $367.26 | 24 | Astellas Pharma US Inc ($85.62) |
| 2020 | $145.94 | 11 | Astellas Pharma US Inc ($38.52) |
| 2019 | $415.58 | 32 | PFIZER INC. ($119.36) |
| 2018 | $584.96 | 44 | Amgen Inc. ($258.51) |
| 2017 | $1,248 | 123 | Lilly USA, LLC ($224.32) |
All Payment Transactions
447 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.38 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: DIABETES | ||||||
| 11/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Biological | ||||||
| 10/24/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Cardiology | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: RESPIRATORY | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Respiratory | ||||||
| 09/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Biological | ||||||
| 08/29/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Cardiology | ||||||
| 08/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Diabetes | ||||||
| 08/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: PAIN | ||||||
| 08/15/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $17.69 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/14/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $29.87 | General |
| Category: RESPIRATORY | ||||||
| 07/31/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Respiratory | ||||||
| 07/29/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: PAIN | ||||||
| 07/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: Diabetes | ||||||
| 07/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: PSYCHIATRY | ||||||
| 07/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Cardiology | ||||||
| 07/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.85 | General |
| Category: Diabetes | ||||||
| 07/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, TRULANCE | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: Gastroenterology | ||||||
| 06/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: DIABETES | ||||||
| 06/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: RESPIRATORY | ||||||
| 06/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, TRULANCE | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Gastroenterology | ||||||
| 06/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Biological | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 698 | 1,060 | $134,142 | $54,714 |
| 2022 | 21 | 889 | 1,391 | $148,277 | $59,771 |
| 2021 | 21 | 1,091 | 1,750 | $145,198 | $58,896 |
| 2020 | 24 | 1,246 | 2,171 | $187,286 | $65,561 |
All Medicare Procedures & Services
83 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 121 | 314 | $62,486 | $27,741 | 44.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 106 | 106 | $29,786 | $12,883 | 43.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 66 | 84 | $10,668 | $5,008 | 46.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 14 | $4,046 | $1,870 | 46.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 71 | 122 | $3,904 | $928.42 | 23.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 69 | 89 | $3,560 | $921.15 | 25.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 19 | 22 | $3,058 | $856.68 | 28.0% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 54 | 96 | $3,264 | $795.84 | 24.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 20 | 23 | $2,162 | $756.91 | 35.0% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 17 | 17 | $3,350 | $689.35 | 20.6% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 14 | 19 | $2,014 | $533.63 | 26.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 35 | 40 | $1,720 | $524.80 | 30.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 16 | 21 | $1,323 | $345.66 | 26.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 31 | 36 | $1,116 | $326.74 | 29.3% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 22 | 29 | $928.00 | $245.63 | 26.5% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 11 | 11 | $451.00 | $178.42 | 39.6% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 14 | 17 | $306.00 | $107.78 | 35.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 121 | 332 | $66,068 | $28,600 | 43.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 95 | 95 | $26,695 | $11,903 | 44.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 74 | 118 | $14,986 | $7,438 | 49.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 43 | 56 | $7,000 | $1,956 | 27.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 95 | 181 | $5,792 | $1,384 | 23.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 22 | 22 | $1,298 | $1,273 | 98.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 85 | 113 | $4,520 | $1,181 | 26.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 25 | 27 | $2,538 | $956.28 | 37.7% |
About Dr. Ivan Jackson, MD
Dr. Ivan Jackson, MD is a Internal Medicine healthcare provider based in Dothan, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1205839362.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ivan Jackson, MD has received a total of $5,987 in payments from pharmaceutical and medical device companies, with $1,029 received in 2024. These payments were reported across 447 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($5,981).
As a Medicare-enrolled provider, Jackson has provided services to 3,924 Medicare beneficiaries, totaling 6,372 services with total Medicare billing of $238,942. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Dothan, AL
- Active Since 05/23/2005
- Last Updated 03/03/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1205839362
Products in Payments
- TRELEGY ELLIPTA (Drug) $461.86
- ELIQUIS (Drug) $335.21
- JARDIANCE (Drug) $304.07
- MOUNJARO (Drug) $260.74
- Prolia (Biological) $249.47
- XIFAXAN (Drug) $246.07
- QULIPTA (Drug) $228.25
- MYRBETRIQ (Drug) $201.87
- NURTEC ODT (Drug) $188.36
- XARELTO (Drug) $185.55
- FREESTYLE LIBRE 2 (Device) $170.68
- TRADJENTA (Drug) $147.12
- Ozempic (Drug) $130.29
- Kerendia (Drug) $126.94
- EVENITY (Biological) $124.40
- UBRELVY (Drug) $120.23
- TRULICITY (Drug) $117.26
- TRINTELLIX (Drug) $111.42
- REXULTI (Drug) $107.70
- ANORO (Drug) $105.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Dothan
Justin Hovey, M.d, M.D
Internal Medicine — Payments: $40,901
Dr. Sebastian Heersink, Md, MD
Internal Medicine — Payments: $33,960
Dr. Christopher Miller, M.d, M.D
Internal Medicine — Payments: $16,529
John Wessner, M.d, M.D
Internal Medicine — Payments: $15,180
Dr. James Conner, M.d, M.D
Internal Medicine — Payments: $14,834
Frank Crockett, M.d, M.D
Internal Medicine — Payments: $14,445